Effects of 'R' (Electro-kinetic Beverage) on Insomnia, Fatigue, and Depression in Breast Cancer Patients Having Adjuvant Chemo

Exclusion Criteria

• •Preexisting diagnosed psychiatric disorder as defined by The Diagnostic and Statistical Manual (DSM) of Mental Disorders (published by the American Psychiatric Association). Subjects with a diagnosis of depression will be allowed to enter into study as long as they have been treated with medication for ≥ 6 months and/or depression is considered to be well controlled
• •Pregnant or lactating
• •Diabetes
• •Concomitant use of any sleeping agents during the course of the study (Anti- anxiety medications will be allowed)
• •Steroid therapy other than the standard prescribed therapy of either of the following during the course of the study:
• •* Dexamethasone 4-12 mg IV on Day 1 of any cycle
• •* Dexamethasone 4-12 mg PO on Day 2 and Day 3 of any cycle
• •Anti-estrogen therapy other than the standard prescribed therapy of one of the following:
• •* Tamoxifen/Nolvadex 20 mg PO daily
• •* Anastrazole/Arimidex 1 mg PO daily
• •* Letrozole/Femara 2.5 mg PO daily
• •* Exemestane/Aromasin 25 mg PO daily
• •Use of any other antiemetic regimen other than the following (with the exception of PO antiemetics):
• •* Emend /Aprepitant150 mg IV on Day 1 of any cycle
• •* Aloxi/Palonosetron 0.25 mg IV on Day 1 of any cycle
• •* Dexamethasone 8 mg IV on Day 1 of any cycle
• •* Dexamethasone 8 mg PO on Day 2 and Day 3 of any cycle
• •* Zofran/Ondansetron 12 mg IV on Day 1 of any cycle
• •* Kytrile/Granisetron 1-2 mg IV on Day 1 of any cycle
• •Therapy with any immunomodulatory or immunosuppressive drugs within 6 months prior to enrollment
• •Known history of positive viral serology test for Human Immunodeficiency Virus (HIV-1), HBsAG and Hepatitis C antibody
• •Any change in the initially prescribed chemotherapy
• •Use of herbal remedies, dietary supplements or mega-vitamins, with the exception of a multi-vitamin
• •Investigator deems the subject to be unable or unwilling to comply with the requirements of the protocol